Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE9096.4534.2 (+0.38 %)

PREV CLOSE ( ) 9062.25

OPEN PRICE ( ) 9093.95

BID PRICE (QTY) 9096.55 (3)

OFFER PRICE (QTY) 9119.45 (12)

VOLUME 27

TODAY'S LOW / HIGH ( )9066.70 9130.95

52 WK LOW / HIGH ( )6301 10653.05

NSE9101.5010 (+0.11 %)

PREV CLOSE( ) 9091.50

OPEN PRICE ( ) 9140.00

BID PRICE (QTY) 9102.50 (2)

OFFER PRICE (QTY) 9112.50 (1)

VOLUME 1311

TODAY'S LOW / HIGH( ) 9050.00 9140.00

52 WK LOW / HIGH ( )6312.75 10691

Chairman	Shilpa Divekar Nirula
Executive Director	Praveen Rao Akkinepally
Non Executive Director	Jesus Javier Diaz Ropero Esteso Sylvia Lorena Varela Ramon Hooi-Bien Chuah
Non Executive Independent Director	Revathy Ashok Monica Widhani
Whole Time Director	Bhavana Agrawal

Incorporation Year : 11-07 1979

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road Bengaluru,
Karnataka-560045 .

Phone : 080 6774 8000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE